Mia Rosenblatt, Associate Director of Policy and Influencing at Breast Cancer Now, said: “We are very concerned that often there can be...

9 November 2020

The Scottish Medicines Consortium (SMC) has today (9 November 2020) approved: Trastuzumab emtansine (Kadcyla) for routine NHS use in Scotland...

9 November 2020

Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: “It is cause for great concern that almost half (48%) of the people...

9 October 2020

NHS England cancer waiting times data from August 2020 shows: The two week wait target for people referred with suspected breast cancer was not...

8 October 2020

The plasmaMATCH trial which investigates whether simple blood tests known as ‘liquid biopsies’ can benefit women with breast cancer by tracking...

11 September 2020

A study from the University of Basal has suggested that lack of oxygen supply to a cancer tumour might encourage cells to break away from the primary...

9 September 2020

The Scottish Medicines Consortium (SMC) has today (7 September 2020) approved Perjeta – given in combination with trastuzumab and chemotherapy...

7 September 2020

A new study published in the BMJ suggests that asingle targeted dose of radiotherapy could be as effective at treating breast cancer as a full course...

20 August 2020

NHS England cancer waiting times data from Q1 2020/21 shows: The two week wait target for people referred with suspected breast cancer was...

14 August 2020